Related references
Note: Only part of the references are listed.Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Emma C. Morris et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Improving safety of cancer immunotherapy via delivery technology
Doudou Hu et al.
BIOMATERIALS (2021)
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial
Stephan Kadauke et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CART cells and clearance of bulky lymphoma
Paul-Joseph Aspuria et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
Qian Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
Paolo F. Caimi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model
Xuedan He et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
CAR T-cell therapy in multiple myeloma: more room for improvement
Phaik Ju Teoh et al.
BLOOD CANCER JOURNAL (2021)
CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy
Yan Yi et al.
CELL DISCOVERY (2021)
Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy
Lei Xue et al.
CELL DISCOVERY (2021)
Cellular networks controlling T cell persistence in adoptive cell therapy
Jack D. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors
Paris Kosti et al.
CELL REPORTS MEDICINE (2021)
The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells
Hannah E. Hughes-Parry et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor
Nicholas G. Minutolo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
A Chemical Switch System to Modulate Chimeric Antigen Receptor T Cell Activity through Proteolysis-Targeting Chimaera Technology
So Myoung Lee et al.
ACS SYNTHETIC BIOLOGY (2020)
Adaptor CAR Platforms-Next Generation of T Cell-Based Cancer Immunotherapy
Claudia Arndt et al.
CANCERS (2020)
Macrophage, the potential key mediator in CAR-T related CRS
Zhaonian Hao et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo
Sarah A. Richman et al.
MOLECULAR THERAPY (2020)
Designed protein logic to target cells with precise combinations of surface antigens
Marc J. Lajoie et al.
SCIENCE (2020)
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
Qibin Liao et al.
BIOMARKER RESEARCH (2020)
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
Jianshu Wei et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial
Stephen J. Schuster et al.
BLOOD ADVANCES (2020)
Chimeric antigen receptor -T cells with cytokine neutralizing capacity
Adrian H. J. Tan et al.
BLOOD ADVANCES (2020)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
Mohit Sachdeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
Gina Ma et al.
STEM CELL REVIEWS AND REPORTS (2019)
Catching a SPY: Using the SpyCatcher-SpyTag and Related Systems for Labeling and Localizing Bacterial Proteins
Daniel Hatlem et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy
Clara H. Karches et al.
CLINICAL CANCER RESEARCH (2019)
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Chelsea Kotch et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Justin R. Klesmith et al.
MOLECULAR PHARMACEUTICS (2019)
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Katrin Mestermann et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Yong Gu Lee et al.
NATURE COMMUNICATIONS (2019)
Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
Noushin Lotfi et al.
FRONTIERS IN IMMUNOLOGY (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Pharmacologic control of CAR-T cell function using dasatinib
Evan W. Weber et al.
BLOOD ADVANCES (2019)
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Jehan Aram et al.
NEUROLOGY AND THERAPY (2019)
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Jang Hwan Cho et al.
CELL (2018)
Nanoteamwork: covalent protein assembly beyond duets towards protein ensembles and orchestras
Anusuya Banerjee et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
David Porter et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
Keishi Adachi et al.
NATURE BIOTECHNOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Jonathan T. Sockolosky et al.
SCIENCE (2018)
Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
Mauro P. Avanzi et al.
CELL REPORTS (2018)
Nanoscale delivery systems for cancer immunotherapy
Zejun Wang et al.
MATERIALS HORIZONS (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq et al.
NATURE BIOTECHNOLOGY (2018)
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
Noelle Frey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
Verena Staedtke et al.
NATURE (2018)
Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
Sophie Viaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Zhenguang Wang et al.
BIOMARKER RESEARCH (2018)
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Iulia Diaconu et al.
MOLECULAR THERAPY (2017)
Masked Chimeric Antigen Receptor for Tumor-Specific Activation
Xiaolu Han et al.
MOLECULAR THERAPY (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Caspase-9: structure, mechanisms and clinical application
Ping Li et al.
ONCOTARGET (2017)
An oxygen sensitive self-decision making engineered CAR T-cell
Alexandre Juillerat et al.
SCIENTIFIC REPORTS (2017)
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy
Sarah M. Larson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia
Sarah K. Tasian et al.
BLOOD (2017)
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Julie C. Fitzgerald et al.
CRITICAL CARE MEDICINE (2017)
Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
Yu Cao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Burkhard Becher et al.
IMMUNITY (2016)
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paulina J. Paszkiewicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage
Irina Ushach et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
David T. Rodgers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Bing-Lan Zhang et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
Targeting folate receptor alpha for cancer treatment
Anthony Cheung et al.
ONCOTARGET (2016)
Tocilizumab-Refractory Cytokine Release Syndrome (CRS) Triggered By Chimeric Antigen Receptor (CAR)-Transduced T Cells May Have Distinct Cytokine Profiles Compared to Typical CRS
Kazusa Ishii et al.
BLOOD (2016)
Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
Min Soo Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
Brian Philip et al.
BLOOD (2014)
Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells
Xiao-Jun Xu et al.
CANCER LETTERS (2014)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti et al.
IMMUNOLOGICAL REVIEWS (2014)
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
Katarzyna Urbanska et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Synthesis of bioactive protein hydrogels by genetically encoded SpyTag-SpyCatcher chemistry
Fei Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Flexible Antigen-Specific Redirection of Human Regulatory T Cells Via a Novel Universal Chimeric Antigen Receptor System
Stefanie Koristka et al.
BLOOD (2014)
Structural basis for molecular recognition of folic acid by folate receptors
Chen Chen et al.
NATURE (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tyrosine hydroxylase and regulation of dopamine synthesis
S. Colette Daubner et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
Xiuli Wang et al.
BLOOD (2011)
Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
Ling Zhang et al.
MOLECULAR THERAPY (2011)
Small-molecule displacement of a cryptic degron causes conditional protein degradation
Kimberly M. Bonger et al.
NATURE CHEMICAL BIOLOGY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Folate-targeted therapeutic and imaging agents for cancer
Philip Stewart Low et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy
Marieke Griffioen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Profound inhibition of antigen-specific T-cell effector functions by dasatinib
Ralf Weichsel et al.
CLINICAL CANCER RESEARCH (2008)
Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
Andrew E. Schade et al.
BLOOD (2008)
Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells
Simon Gaudreau et al.
JOURNAL OF IMMUNOLOGY (2007)
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation
Siok-Keen Tey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy
Takeya Sato et al.
MOLECULAR THERAPY (2007)
Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associatd with an expansion of FoxP3+, regulatory T cells
Jian Rong Sheng et al.
JOURNAL OF IMMUNOLOGY (2006)
Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes
Beatrice Clemenceau et al.
BLOOD (2006)
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
C Berger et al.
BLOOD (2006)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know
YF Shi et al.
CELL RESEARCH (2006)
CD40/CD154 interactions at the interface of tolerance and immunity
SA Quezada et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease
M Serafini et al.
HUMAN GENE THERAPY (2004)
Catecholamines in a macrophage cell line
SW Brown et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Share Paper
